A long study of 3,000 men in the U.S. with enlarged prostates concludes they are better off if they receive both, not just one, of two drugs that help treat their condition. Many men with the problem receive either finasteride or doxazosin, but not both, and the study suggests those who receive both are 66% less likely to see their condition worsen.

Full Story:

Related Summaries